SMYD3 is a histone methyltransferase that plays a significant role in transcriptional regulation, methylation of histone and non-histone targets, and cancer development. It is expressed in various organs and tissues and is particularly involved in the initiation and progression of multiple cancers, including colorectal, hepatocellular, breast, and ovarian cancer.